- Home
- LVRO vs ENTA Comparison
LVRO vs ENTA Comparison
Compare LVRO & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVRO
- ENTA
- Stock Information
- Founded
- LVRO 2017
- ENTA 1995
- Country
- LVRO Brazil
- ENTA United States
- Employees
- LVRO N/A
- ENTA N/A
- Industry
- LVRO Blank Checks
- ENTA Biotechnology: Pharmaceutical Preparations
- Sector
- LVRO Finance
- ENTA Health Care
- Exchange
- LVRO Nasdaq
- ENTA Nasdaq
- Market Cap
- LVRO 205.1M
- ENTA 164.6M
- IPO Year
- LVRO N/A
- ENTA 2013
- Fundamental
- Price
- LVRO $1.38
- ENTA $11.04
- Analyst Decision
- LVRO Sell
- ENTA Strong Buy
- Analyst Count
- LVRO 3
- ENTA 5
- Target Price
- LVRO $1.88
- ENTA $21.00
- AVG Volume (30 Days)
- LVRO 10.6K
- ENTA 539.2K
- Earning Date
- LVRO 10-31-2025
- ENTA 11-24-2025
- Dividend Yield
- LVRO N/A
- ENTA N/A
- EPS Growth
- LVRO N/A
- ENTA N/A
- EPS
- LVRO N/A
- ENTA N/A
- Revenue
- LVRO $1,667,345,189.00
- ENTA $64,806,000.00
- Revenue This Year
- LVRO N/A
- ENTA $0.07
- Revenue Next Year
- LVRO $11.45
- ENTA N/A
- P/E Ratio
- LVRO N/A
- ENTA N/A
- Revenue Growth
- LVRO N/A
- ENTA N/A
- 52 Week Low
- LVRO $1.25
- ENTA $4.09
- 52 Week High
- LVRO $5.60
- ENTA $15.34
- Technical
- Relative Strength Index (RSI)
- LVRO 39.01
- ENTA 53.80
- Support Level
- LVRO $1.30
- ENTA $10.30
- Resistance Level
- LVRO $1.49
- ENTA $11.45
- Average True Range (ATR)
- LVRO 0.08
- ENTA 0.60
- MACD
- LVRO -0.01
- ENTA -0.13
- Stochastic Oscillator
- LVRO 25.81
- ENTA 35.09
About LVRO Lavoro Limited
Lavoro Ltd operates in the agricultural inputs retail market, with operations spread across Brazil and Colombia, and an emergent agricultural input trading company in Uruguay. The reportable segments of the company include the Brazil Ag Retail, which comprises companies dedicated to the distribution of agricultural inputs such as crop protection, seeds, fertilizers and specialty products, in Brazil; Latam Ag Retail, which includes companies dedicated to the distribution of agricultural inputs outside Brazil (predominantly in Colombia); and the Crop Care. A substantial part of the company's overall revenue is generated from its Brazil Ag Retail segment.
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.